Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study.
Blood
; 137(18): 2438-2449, 2021 05 06.
Article
in En
| MEDLINE
| ID: mdl-33270832
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Withholding Treatment
/
Complement Inactivating Agents
/
Antibodies, Monoclonal, Humanized
/
Atypical Hemolytic Uremic Syndrome
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
/
Newborn
Language:
En
Journal:
Blood
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: